Related Experiment Video
Updated: Jun 20, 2025

07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.0K
Prostate cancer perspective: Africa versus the world
Summary
Prostate cancer (PCa) presents differently in Africa compared to developed nations. Black African men face higher mortality rates due to advanced disease, highlighting significant global health disparities.
Area of Science:
- Oncology
- Global Health
- Epidemiology
Background:
- Prostate cancer (PCa) is a leading cancer diagnosis in men globally.
- Significant disparities exist in PCa incidence and outcomes between developed countries and Africa.
- Black African men disproportionately experience advanced disease and higher mortality.
Purpose of the Study:
- To review the global and African burden of prostate cancer.
- To compare PCa presentation and outcomes in Africa versus developed regions.
- To explore reasons for observed differences and address racial disparities in PCa.
Main Methods:
- Literature review focusing on global and African PCa epidemiology.
- Comparative analysis of PCa data between geographic regions.
- Examination of biological, socioeconomic, and institutional factors influencing PCa outcomes.
Main Results:
- PCa incidence is rising globally, with distinct patterns in Africa.
- Advanced disease at diagnosis is more common in African populations.
- Socioeconomic and institutional factors exacerbate PCa disparities in Africa.
Conclusions:
- Prostate cancer presents as a 'different' disease in Africa due to a complex interplay of factors.
- Addressing racial disparities and improving healthcare infrastructure are crucial for reducing PCa mortality in Africa.
- Further research is needed to understand and mitigate these global health inequities.
Related Concept Videos
Cancer Survival Analysis
336
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
336
Disorders of the Male Reproductive System
377
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
377
Cancer Vaccines
348
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
348
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K

